The goals of this proposal relate to deepening understanding of the consequences of activation of alpha1 adrenergic receptors, with emphasis on signal transduction mechanisms in vascular smooth muscle cells. Preliminary data indicate that the contribution of alpha1 receptors to vascular cell growth has been underestimated in comparison to peptide growth factors. The proposal serves to continue exploration of biologically interesting alpha1 receptor mechanisms that could also have clinical significance for atherosclerosis and vascular growth in hypertension. The proposal has two major aims: 1 Signal transduction mechanisms of al receptors in vascular smooth muscle and transfected NIH3T3 cells. al receptors activate a variety of signaling pathways including MAP kinases, PI 3-kinase, and p70S6 kinase. These pathways have importance for receptor-activated increases in protein and DNA synthesis. The primary purpose of this aim is to develop deeper insight into the mechanisms used by alpha1 receptors to activate these signaling pathways and to contrast them with the actions of angiotensin II and other growth factors such as platelet derived growth factor. 1A. Investigate the mechanism for the essential role of Ca2+ in alpha1 receptor- mediated activation of MAP kinase and p70S6 kinase and tyrosine protein phosphorylation, especially of phospholipase Cgamma. 1B. Determine the role of alpha1 receptors in the activation of PI-3 kinase isoforms and p70S6 kinase. 1C. alpha1 and angiotensin II receptors stimulate PI 3-kinase activity in vascular smooth muscle cells yet do not stimulate PKB which is generally activated down-stream of PI 3-kinase. What is the mechanism responsible for this inability to activate PKB? 2. Regulation of gene expression by alpha1 receptors toys Preliminary results suggest that alpha1 receptors increase expression of a range of genes, including nerve growth factor and various tyrosine kinases and transcription factors. We propose to characterize using microarray gene chip technology the pattern of gene expression induced by alpha1 receptors in vascular smooth muscle and by specific alpha1 receptor subtypes in transfected HEK-293 cells. We will then characterize in detail the effects of alpha1 receptors on expression of identified genes of particular biological interest, both at the mRNA and protein level, as well as investigating possible biological implications of the change in expression of these proteins.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL041315-12
Application #
6127060
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1988-07-01
Project End
2004-03-31
Budget Start
2000-04-20
Budget End
2001-03-31
Support Year
12
Fiscal Year
2000
Total Cost
$227,675
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Chen, Jin; Hoffman, Brian B; Isseroff, R Rivkah (2002) Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate-independent mechanism. J Invest Dermatol 119:1261-8
Hu, Zhuo-Wei; Kerb, Reinhold; Shi, Xiao-You et al. (2002) Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. J Pharmacol Exp Ther 303:563-73
Hu, Z W; Hoffman, B B (2000) Nuclear run-on assays for measurement of adrenergic receptor transcription rate. Methods Mol Biol 126:169-80
Hu, Z W; Shi, X Y; Lin, R Z et al. (1999) alpha1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase. J Pharmacol Exp Ther 290:28-37
Hu, Z W; Shi, X Y; Lin, R Z et al. (1999) Contrasting signaling pathways of alpha1A- and alpha1B-adrenergic receptor subtype activation of phosphatidylinositol 3-kinase and Ras in transfected NIH3T3 cells. Mol Endocrinol 13:3-14
Chen, J; Lin, R; Hu, Z W et al. (1999) alpha1-adrenergic receptor activation of c-fos expression in transfected rat-1 fibroblasts: role of Ca2+. J Pharmacol Exp Ther 289:1376-84
Hu, Z W; Shi, X Y; Hoffman, B B (1998) Doxazosin inhibits proliferation and migration of human vascular smooth-muscle cells independent of alpha1-adrenergic receptor antagonism. J Cardiovasc Pharmacol 31:833-9
Lin, R Z; Chen, J; Hu, Z W et al. (1998) Phosphorylation of the cAMP response element-binding protein and activation of transcription by alpha1 adrenergic receptors. J Biol Chem 273:30033-8
Lin, R Z; Hu, Z W; Chin, J H et al. (1997) Heat shock activates c-Src tyrosine kinases and phosphatidylinositol 3-kinase in NIH3T3 fibroblasts. J Biol Chem 272:31196-202
Okazaki, M; Hu, Z W; Fujinaga, M et al. (1996) Alpha 1 adrenergic receptor activation of proto-oncogene expression in arterial smooth muscle: regulation by nitric oxide and vascular injury. Recept Signal Transduct 6:165-78

Showing the most recent 10 out of 28 publications